相关实验视频

Updated: May 13, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

先进和转移的三阴性乳腺癌-潜在的新治疗方法

Monika Pajewska^1,2, Olga Partyka^1,2, Aleksandra Czerw^1,2

¹Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.

|April 14, 2025

概括

本研究审查了高级三阴性乳腺癌 (TNBC) 治疗的临床试验. 它强调了正在进行的针对这种侵袭性癌症亚型的新疗法的研究,重点关注患者的治疗结果和安全性.

科学领域:

在瘤学瘤学.
临床试验研究研究临床试验临床试验

背景情况:

乳腺癌是全球女性癌症死亡的主要原因,到2022年诊断出超过200万例.
三阴性乳腺癌 (TNBC) 是一种攻击性的亚型,占病例的10-20%,并且具有转移的高风险 (40%).

研究的目的:

介绍目前正在进行的临床试验,研究高级和转移性TNBC的新疗法.
整合有关TNBC新兴治疗策略的信息.

主要方法:

在clinicaltrials.gov数据库中进行系统搜索.
包括I期和II期随机对照试验 (RCT).
专注于主要终点,如客观反应率,不良事件,无进展生存率和病理完整反应.

主要成果:

确定并总结了针对晚期和转移性TNBC的正在进行的临床试验.
突出了这些试验中评估的关键终点,包括疗效和安全指标.
承认I/II期试验数据的初步性质.

结论:

目前的临床试验正在探索高级和转移性TNBC的创新治疗方法.
这些试验的未来结果对于为临床指导方针提供信息和改善TNBC患者护理至关重要.
需要进一步的研究才能充分理解这些新疗法的影响.

关键词:

美国TNBC电视台晚期乳腺癌是什么?转移性乳腺癌转移性乳腺癌新的治疗方法.治疗治疗治疗治疗治疗治疗

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.